Hemorrhoidal Artery Embolization for Treating Internal Hemorrhoids Evaluating Long-Term Symptom Relief and Safety Over One Year

What this Trial Is About

Researchers are evaluating hemorrhoidal artery embolization HAE, a new procedure for treating symptomatic internal hemorrhoids. HAE works by blocking enlarged arteries in the rectal or hemorrhoidal area to reduce abnormal blood flow, aiming to improve symptoms such as bleeding. Earlier reports suggest HAE may be safe and effective, but more research is needed to understand its long-term effects using different embolization materials in a broader patient population with hemorrhoidal disease. This trial involves 22 patients with grades I to III internal hemorrhoids who have symptoms including a French Bleeding Score of at least four and who have refused or cannot have surgery or other minimally invasive treatments. After an initial clinic visit to confirm eligibility, participants will receive the HAE procedure. The study includes follow-up visits in the clinic at 1, 3, 6, and 12 months after treatment to monitor progress and outcomes. Participants will be assessed for improvements in bleeding symptoms using the French Bleeding Score, as well as changes in other hemorrhoid-related symptoms, pain, and patient satisfaction. Researchers will also track the need for further medical or surgical treatments. Safety and technical success of the HAE procedure will be monitored throughout the year-long study, with all follow-up visits designed to evaluate symptom changes and overall treatment impact.

Hemorrhoidal Artery Embolization: Longitudinal Impact On Symptoms (HELIOS)